Utility of the Use of N-acetylcysteine Associated With Conventional Treatment in Patients With Severe Acute Alcoholic Hepatitis (Maddrey> 32)

NAUnknownINTERVENTIONAL
Enrollment

390

Participants

Timeline

Start Date

April 30, 2022

Primary Completion Date

July 31, 2023

Study Completion Date

July 31, 2023

Conditions
Alcoholic Hepatitis
Interventions
DRUG

N-acetylcysteine

"Day 1: 150 mg/kg in 250ml 5% glucose over 30min + 50mgr/kg in 500ml glucose over 4h + 100mgr/kg in 1000ml glucose over 16h intravenously.~Day 2-14: 100mgr/kg in 1000 ml glucose/24h intravenously. Day 15 until end of corticosteroid treatment: NAC 600mg orally every 24h."

Trial Locations (1)

01009

Ana Belén Fernández Laso, Vitoria-Gasteiz

All Listed Sponsors
lead

Bioaraba Health Research Institute

NETWORK